NUMI:CC News and Press, Numinus Wellness Inc. From 06/10/22

TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Welln...

Numinus completes acquisition of Novamind and announces executive appointments Canada NewsWire Transaction has completed following shareholder and court approvals Novamind shareholders and RSU holders have been issued 0.84 Numinus shares per Novamind share ...

Numinus announces shareholder approval of resolution in connection with the proposed acquisition of Novamind Canada NewsWire Novamind shareholders, at a separate meeting held today, have also approved the transaction Transaction expected to be completed on or...

Numinus announces ISS recommends shareholders vote in favor of the share issuance to acquire Novamind Canada NewsWire ISS states that the proposed acquisition is in the best interest of Numinus shareholders Shareholders are encouraged to vote their common sha...

Numinus Wellness Receives Health Canada Special Access Program Applicant Approval to Provide Psychedelic-assisted Therapy Treatment Canada NewsWire Approval Marks Numinus' First use of Psilocybin-Assisted Therapy Treatment Outside of Clinical Trials VANCOUVER...

Numinus to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022 Canada NewsWire VANCOUVER, BC , May 11, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innov...

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons , the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman says LSD and MDMA helped him alleviate symptoms rel...

Numinus Mails Materials for Special Meeting of Shareholders and Announces Interim Court Order for Plan of Arrangement Canada NewsWire Shareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 at 11:00 a.m. PT ...

Numinus to Participate in Upcoming Research & Industry Conferences Numinus to Participate in Upcoming Research & Industry Conferences Canada NewsWire Numinus leaders will speak at Catalyst, Psychedelic Therapeutics & From Research to Reality V...

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27 th and 28 th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing....